iTeos Therapeutics, Inc.
NASDAQ:ITOS
7.25 (USD) • At close April 30, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Assets: | |||||||
| Current Assets: | |||||||
| Cash & Cash Equivalents
| 142.131 | 251.177 | 284.803 | 848.537 | 336.326 | 19.868 | 21.988 |
| Short Term Investments
| 352.517 | 280.739 | 328.359 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 494.648 | 531.916 | 613.162 | 848.537 | 336.326 | 19.868 | 21.988 |
| Net Receivables
| 3.691 | 6.5 | 2.435 | 12.09 | 0.325 | 5.329 | 1.158 |
| Inventory
| 0 | 0 | 0 | -10.086 | -0.325 | 0 | 0 |
| Other Current Assets
| 11.2 | 12.236 | 12.701 | 14.086 | 2.893 | 0.879 | 0.526 |
| Total Current Assets
| 509.539 | 550.652 | 628.298 | 874.713 | 339.544 | 26.076 | 23.672 |
| Non-Current Assets: | |||||||
| Property, Plant & Equipment, Net
| 9.984 | 10.732 | 6.773 | 7.401 | 1.352 | 1.336 | 1.156 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 160.354 | 100.539 | 118.225 | 0.298 | 0.128 | 0.122 | 0.066 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 7.099 | 5.665 | 1.695 | 2.3 | 3.534 | 3.21 | 2.497 |
| Total Non-Current Assets
| 177.437 | 116.936 | 126.693 | 9.999 | 5.014 | 4.668 | 3.719 |
| Total Assets
| 686.976 | 667.588 | 754.991 | 884.712 | 344.558 | 30.744 | 27.391 |
| Liabilities & Equity: | |||||||
| Current Liabilities: | |||||||
| Account Payables
| 8.503 | 11.293 | 7.662 | 5.145 | 3.026 | 1.174 | 1.367 |
| Short Term Debt
| 1.336 | 1.251 | 1.672 | 1.54 | 0 | 0 | 0 |
| Tax Payables
| 1.923 | 6.365 | 1.434 | 7.544 | 0 | 0 | 0 |
| Deferred Revenue
| 1.397 | 2.063 | 13.775 | 281.052 | 4.486 | 2.36 | 0.39 |
| Other Current Liabilities
| 27.201 | 19.042 | 30.713 | 21.346 | 7.486 | 9.662 | 3.257 |
| Total Current Liabilities
| 40.36 | 40.014 | 42 | 304.124 | 14.998 | 13.196 | 5.014 |
| Non-Current Liabilities: | |||||||
| Long Term Debt
| 0 | 4.807 | 3.837 | 4.571 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 56.322 | 47.539 | 45.822 | 23.197 | 6.363 | 1.879 | 7.324 |
| Total Non-Current Liabilities
| 56.322 | 52.346 | 49.659 | 27.768 | 6.363 | 1.879 | 7.324 |
| Total Liabilities
| 96.682 | 92.36 | 91.659 | 331.892 | 21.361 | 15.075 | 12.338 |
| Equity: | |||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 344.558 | 51.757 | 25.731 |
| Common Stock
| 0.037 | 0.036 | 0.036 | 0.035 | 0.035 | 0.001 | 0.087 |
| Retained Earnings
| -9.781 | 124.633 | 237.275 | 140.623 | -73.898 | -35.865 | -10.765 |
| Accumulated Other Comprehensive Income/Loss
| -15.999 | -13.24 | -9.644 | -1.018 | 0.617 | -0.224 | -0.011 |
| Other Total Stockholders Equity
| 616.037 | 463.799 | 435.665 | 413.18 | 396.443 | -51.757 | 0.011 |
| Total Shareholders Equity
| 590.294 | 575.228 | 663.332 | 552.82 | 323.197 | 15.669 | 15.053 |
| Total Equity
| 590.294 | 575.228 | 663.332 | 552.82 | 323.197 | 15.669 | 15.053 |
| Total Liabilities & Shareholders Equity
| 686.976 | 667.588 | 754.991 | 884.712 | 344.558 | 30.744 | 27.391 |